Ulmedt SRL
Ulmedt reported total assets of 87,797 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Aug 2026).
The score of Ulmedt shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +363 % Total assets +24 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ulmedt's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 23 Sep 2022
Ulmedt's financial analysis
- Solvency77.0%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ulmedt
Ulmedt's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0895.965.442
- VAT number
- BE0895965442
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 15 Feb 2008
- Registered office
- 3590 Diepenbeek
- Latest accounts
- 2025 · filed on 29 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Ulmedt (SRL) has been based in Diepenbeek since 2008, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 2,654 € and equity of 67,583 €; its revenue is not published. Its solvency stands at 77.0%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Ulmedt
Companies in the same business, of comparable size and area, outside its group.
- Verachtert Digital Manufacture of medical and dental instruments and supplies Antwerp · balance sheet €1.08m
- Extraphar Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 10,258 €
- Yourope Trading Wholesale of pharmaceutical and medical goods Brussels · balance sheet 89,184 €
- XMED iQ France BeNeLux Wholesale of pharmaceutical and medical goods Brussels · balance sheet 653,917 €
- Novalab Wholesale of pharmaceutical and medical goods Uccle · balance sheet 113,734 €
- Orbi-Pharma International Wholesale of pharmaceutical and medical goods Bierbeek · balance sheet 161,674 €
- LexTec Wholesale of pharmaceutical and medical goods Zemst · balance sheet 83,131 €
- Allmedics Wholesale of pharmaceutical and medical goods Keerbergen · balance sheet 281,788 €
Frequently asked questions about Ulmedt
What is the revenue of Ulmedt?
Ulmedt files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ulmedt?
In Belgium, the VAT number is the company number prefixed with BE: BE0895965442 for Ulmedt, if the company is VAT-registered. Its company number (CBE) is 0895.965.442.
Where is the registered office of Ulmedt?
According to the CBE register, the registered office of Ulmedt is in 3590 Diepenbeek.
What is the equity of Ulmedt?
At the close of the 2025 financial year, the equity of Ulmedt amounts to 67,583 €, a solvency of 77.0% of total assets.
Who manages Ulmedt?
The register lists 1 active mandates at Ulmedt. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ulmedt
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →